[vc_row][vc_column][vc_btn title=”Article: Physical Therapy versus Glucocorticoid Injection for Osteoarthritis of the Knee” color=”info” size=”lg” align=”left” link=”url:https%3A%2F%2Fimiowa.com%2Fwp-content%2Fuploads%2F2022%2F05%2FSalomone_Physical-Therapy-versus-Glucocorticoid-Injection-for-Osteoarthritis-of-the-Knee.pdf”][vc_column_text]Dr. John Salomone, PGY3 Mentor: Dr. Wendy Fiordellisi [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
[vc_row][vc_column][vc_btn title=”Article: CT or Invasive Coronary Angiography in Stable Chest Pain” color=”info” size=”lg” align=”left” link=”url:https%3A%2F%2Fimiowa.com%2Fwp-content%2Fuploads%2F2022%2F05%2FBullis_CT-or-Invasive-Coronary-Angiography-in-Stable-Chest-Pain.pdf”][vc_column_text]Dr. Tyler Bullis, PGY3 Mentor: Dr. Justin Smock [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
[vc_row][vc_column][vc_btn title=”Article: Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis” color=”info” size=”lg” align=”left” link=”url:https%3A%2F%2Fimiowa.com%2Fwp-content%2Fuploads%2F2022%2F05%2FKidder-Yu_Partial-Oral-versus-Intravenous-Antibiotic-Treatment-of-Endocarditis.pdf”][vc_column_text]Dr. Ian Kidder, PGY3 and Dr. Qiujun Yu , PGY3 Mentor: Dr. Jason Barker [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
[vc_row][vc_column][vc_btn title=”Article: IABP in Cardiogenic Shock” color=”info” size=”lg” align=”left” link=”url:https%3A%2F%2Fimiowa.com%2Fintraaortic-balloon-pump-in-cardiogenic-shock-complicating-acute-myocardial-infarction-long-term-6-year-outcome-of-the-randomized-iabp-shock-ii-trial|title:Intraaortic%20Balloon%20Pump%20in%20Cardiogenic%20Shock%20Complicating%20Acute%20Myocardial%20Infarction%3A%20Long-Term%206-Year%20Outcome%20of%20the%20Randomized%20IABP-SHOCK%20II%20Trial”][vc_column_text]Presenter: Dr. Jared Robl, PGY3 Mentor: Dr. Paul Lindower [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
[vc_row][vc_column][vc_btn title=”Article: Insights From the ISCHEMIA Trial” color=”info” size=”lg” align=”left” link=”url:https%3A%2F%2Fimiowa.com%2Fwp-content%2Fuploads%2F2022%2F04%2FAbdelhamid_Initial-Invasive-vs-Conservative-Managemetn-of-Stable-Ischemic-Heart-Disease-in-Patinets-with-a-Hx-for-HF-or-LV-dysfunction.pdf”][vc_column_text]Presenter: Dr. Ahmed Abdelhamid, PGY3 Mentor: Dr. Richard Hoffman [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
[vc_row][vc_column][vc_btn title=”Article: EMPEROR-preserved: SGLT2 inhibitors breakthrough in the management of HFpEF” color=”info” size=”lg” align=”left”][vc_column_text]Presenter: Dr. Adil Hassan, PGY3 Mentor: Dr. Mohamed Abidian [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
[vc_row][vc_column][vc_btn title=”Article: Evaluating Vitamin C in Septic Shock ” color=”info” size=”lg” align=”left” link=”url:https%3A%2F%2Fimiowa.com%2Fwp-content%2Fuploads%2F2022%2F03%2FChang_Evaluating-Vitamin-C-in-Septic-Shock-A-Randomized-Controlled-Trial-of-Vitamin-C-Monotherapy.pdf”][vc_column_text]Presenter: Dr. Benny Chang, PGY3 Mentor: Dr. Katie Harris [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
[vc_row][vc_column][vc_btn title=”Article” color=”info” size=”lg” align=”left” link=”url:https%3A%2F%2Fimiowa.com%2Fwp-content%2Fuploads%2F2022%2F02%2FHung_Molnupiravir-for-Oral-Treatment-of-Covid-19-in-Nonhospitalized-Patients.pdf”][vc_column_text]Dr. Chermaine Hung, PGY3 [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
[vc_row][vc_column][vc_btn title=”Article” color=”primary” size=”lg” align=”left”][vc_column_text]Presenters: Dr. Mackenzie Hines and David Olafsson [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
- 1
- 2